Through our partnership with BeiGene, a pharmaceutical company who recently received approval for their first oncology agent, Brukinsa (indicated for the treatment of adult patients with mantle cell lymphoma who have received one prior therapy), oncology practices utilizing AssistPoint® can now use the standardized digital enrollment feature for patients needing to enroll in the myBeiGene patient support program. Financial counselors will be able to save time, compress their workflow, and monitor the status of the patient application for the myBeiGene patient support program directly within AssistPoint®.
For more information on the myBeiGene Patient Support program please visit brukinsa.com
